Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 1 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-08 Beaurang Pierre Chief Business Officer Sale −2,810 $36.48 $103K 4,690
2021-03-08 Beaurang Pierre Chief Business Officer Sale −4,490 $37.31 $168K 200
2021-03-08 Beaurang Pierre Chief Business Officer Sale −200 $38.34 $8K 0
2021-03-08 Beaurang Pierre Chief Business Officer Exercise or conversion · Employee Stock Option (right to buy) −7,500 6,726
2021-03-01 Hansen Gwenn Chief Scientific Officer Exercise or conversion +800 $7.26 $6K 14,604
2021-03-01 Hansen Gwenn Chief Scientific Officer Sale −800 $35.95 $29K 13,804
2021-03-01 Hansen Gwenn Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −800 75,066
2021-02-24 van Houte Hans Chief Financial Officer Exercise or conversion +20,393 $1.20 $24K 20,393
2021-02-24 van Houte Hans Chief Financial Officer Exercise or conversion +13,197 $1.86 $25K 33,590
2021-02-24 van Houte Hans Chief Financial Officer Exercise or conversion +1,829 $7.26 $13K 35,419
2021-02-24 van Houte Hans Chief Financial Officer Sale −35,419 $39.90 $1.4M 0
2021-02-24 van Houte Hans Chief Financial Officer Exercise or conversion · Employee Stock Option (right to buy) −20,393 9,027
2021-02-24 van Houte Hans Chief Financial Officer Exercise or conversion · Employee Stock Option (right to buy) −13,197 20,136
2021-02-24 van Houte Hans Chief Financial Officer Exercise or conversion · Employee Stock Option (right to buy) −1,829 36,504
2021-02-22 van Houte Hans Chief Financial Officer Exercise or conversion +1,417 $0.84 $1K 1,417
2021-02-22 van Houte Hans Chief Financial Officer Exercise or conversion +3,913 $1.20 $5K 5,330
2021-02-22 van Houte Hans Chief Financial Officer Sale −5,330 $39.93 $213K 0
2021-02-22 van Houte Hans Chief Financial Officer Exercise or conversion · Employee Stock Option (right to buy) −1,417 68,333
2021-02-22 van Houte Hans Chief Financial Officer Exercise or conversion · Employee Stock Option (right to buy) −3,913 29,420
2021-02-18 van Houte Hans Chief Financial Officer Exercise or conversion +13,583 $0.84 $11K 13,583

Page 38 of 42 · 829 trades